Trials (Fondazione Policlinico Universitario Agostino Gemelli IRCCS): Revision history

15 December 2025

• curprev 12:4212:42, 15 December 2025‎ Francine talk contribs‎ 212,403 bytes +218‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 212,185 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 01:2501:25, 4 December 2025‎ Larysse talk contribs‎ 210,484 bytes +47‎ No edit summary undo

2 December 2025

• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 210,437 bytes +90‎ Update categories. undo

4 December 2023

• curprev 18:1318:13, 4 December 2023‎ Francine talk contribs‎ 210,347 bytes +210,347‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Fondazione Policlinico Universitario Agostino Gemelli IRCCS page '''NCTID''': NCT05323656 '''Title''': A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) '''Study Summary''': The primary objective of this study is to compare the change in tumour size per Response Evaluation Criteria in Solid Tumours Version..."